Aslan Sinem, Anıl Hülya, Kaya Muhammet, Harmancı Koray
Department of Pediatric Allergy and Immunology, Eskisehir Osmangazi University Faculty of Medicine, Eskisehir, Turkey.
Pediatr Allergy Immunol. 2025 Apr;36(4):e70085. doi: 10.1111/pai.70085.
Local anesthetics (LAs) are widely utilized to provide analgesia in minor surgical interventions. Although patients are frequently referred for suspected LA allergies in clinical practice, confirmed cases of immediate-type hypersensitivity remain rare. This study aims to establish an optimal diagnostic protocol for immediate-type LA allergy in children and to assess the practicality and reliability of an alternative diagnostic approach for hypersensitivity testing of amide-type local anesthetics.
The medical records of patients diagnosed with suspected immediate-type reactions to LAs administered by pediatric dentists between January 2019 and August 2024 were retrospectively reviewed. All children underwent a skin prick test (SPT), followed if negative by an intradermal test (IDT) at a 1:10 dilution. If intradermal testing was also negative, a subcutaneous provocation test was subsequently performed.
A total of 88 patients (47 boys, 41 girls), with a mean age of 8.5 ± 3.5 years, were included. In most cases (n = 59, 67%), the suspected LA was unidentified. Among the known agents, articaine (n = 18, 20.5%) and lidocaine (n = 11, 12.5%) were the most frequently reported. IDT results were positive in 11 patients (12.5%), with articaine in 8 cases (61.5%), prilocaine in 3 cases (23%), and lidocaine in 2 cases (15.5%). Intradermal testing at a 1:10 dilution demonstrated a high negative predictive value (99%) for immediate-type reactions.
For the diagnosis of immediate-type LA allergy, including cases with a history of anaphylaxis, an IDT at a 1:10 dilution following a negative SPT, followed by subcutaneous provocation, may serve as a time-efficient and reliable diagnostic strategy.
局部麻醉药(LAs)广泛用于小型外科手术的镇痛。尽管在临床实践中患者经常因疑似局部麻醉药过敏前来就诊,但确诊的速发型超敏反应病例仍然很少。本研究旨在建立儿童速发型局部麻醉药过敏的最佳诊断方案,并评估酰胺类局部麻醉药超敏反应检测替代诊断方法的实用性和可靠性。
回顾性分析2019年1月至2024年8月间被诊断为对儿科牙医使用的局部麻醉药有疑似速发型反应的患者的病历。所有儿童均接受皮肤点刺试验(SPT),若结果为阴性,则进行1:10稀释的皮内试验(IDT)。如果皮内试验也为阴性,则随后进行皮下激发试验。
共纳入88例患者(47例男孩,41例女孩),平均年龄8.5±3.5岁。在大多数病例(n = 59,67%)中,疑似的局部麻醉药未明确。在已知药物中,阿替卡因(n = 18,20.5%)和利多卡因(n = 11,12.5%)是最常报告的。11例患者(12.5%)的皮内试验结果为阳性,其中阿替卡因8例(61.5%),丙胺卡因3例(23%),利多卡因2例(15.5%)。1:10稀释的皮内试验对速发型反应显示出较高的阴性预测值(99%)。
对于速发型局部麻醉药过敏的诊断,包括有过敏反应病史的病例,皮肤点刺试验阴性后进行1:10稀释的皮内试验,随后进行皮下激发试验,可能是一种省时且可靠的诊断策略。